Detalles de la búsqueda
1.
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Hepatology
; 74(6): 2952-2964, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34255381
2.
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
J Hepatol
; 73(3): 540-548, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32243960
3.
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy.
Gastroenterology
; 157(6): 1506-1517.e1, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31401140
4.
Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis.
Clin Gastroenterol Hepatol
; 16(11): 1811-1819.e4, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29306043
5.
Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.
Hepatology
; 66(4): 1090-1101, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28504842
6.
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study.
Gut
; 66(10): 1844-1852, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27418632
7.
Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response.
Gastroenterology
; 151(6): 1131-1140.e5, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565882
8.
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study.
Clin Infect Dis
; 63(6): 776-783, 2016 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27325691
9.
Reply to: "HCV treatment in cirrhotic patients: Should we use a different approach for patients awaiting a liver transplant".
J Hepatol
; 73(4): 985-986, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32682538
10.
Safety profile of boceprevir and telaprevir in chronic hepatitis C: real world experience from HCV-TARGET.
J Hepatol
; 62(2): 286-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25218788
11.
Public-Private Partnership: Targeting Real-World Data for Hepatitis C Direct-Acting Antivirals.
Gastroenterology
; 153(3): 626-631, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28757271
12.
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.
Hepatol Commun
; 3(10): 1388-1399, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31592494
Resultados
1 -
12
de 12
1
Próxima >
>>